Search details
1.
Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation.
BMC Cancer
; 22(1): 47, 2022 Jan 08.
Article
in English
| MEDLINE | ID: mdl-34996412
2.
Real-world integration of genomic data into the electronic health record: the PennChart Genomics Initiative.
Genet Med
; 23(4): 603-605, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33299147
3.
Attitudes toward pharmacogenetics in patients undergoing CYP2C19 testing following percutaneous coronary intervention.
Per Med
; 19(2): 93-101, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34984913
4.
Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing.
Front Oncol
; 12: 859846, 2022.
Article
in English
| MEDLINE | ID: mdl-35865463
5.
SARS-CoV-2 seropositivity and seroconversion in patients undergoing active cancer-directed therapy.
medRxiv
; 2021 Jan 16.
Article
in English
| MEDLINE | ID: mdl-33469597
6.
SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed Therapy.
JCO Oncol Pract
; 17(12): e1879-e1886, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34133219
7.
DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical Implementation.
Pharmacotherapy
; 40(11): 1108-1129, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32985005
Results
1 -
7
de 7
1
Next >
>>